New data were added to SFARI Gene in December 2016. This data release included updated gene scores for candidate autism risk genes, new animal models, and new copy number variant loci associated with autism.
New Simons VIP Phase 2 data have recently been added to SFARI Base. This data release includes phenotypic data from individuals with 16p11.2 copy number variants (CNVs), 1q21.1 CNVs, and mutations in the following single genes: SCN2A, GRIN2B, ADNP and HIVEP2.
SFARI is pleased to announce that it has selected six finalists in response to the 2016 Bridge to Independence Award request for applications. This awards program is intended to invest in the next generation of top autism investigators by identifying talented early-career scientists and facilitating their transition to an independent research career.
SFARI is pleased to announce that it has awarded 14 grants over the past year in response to the Explorer Awards request for applications.
SFARI is pleased to announce that it has awarded 27 grants (21 Pilot Awards and 6 Research Awards) in response to the 2016 Pilot and Research Awards request for applications.
Presentations that will be given by SFARI Investigators at Neuroscience 2016 in San Diego (November 12-16) are highlighted.
New Simons VIP data have recently been added to SFARI Base. This data release includes phenotypic data from individuals with 16p11.2 copy number variants (CNVs), 1q21.1 CNVs, GRIN2B mutations and SCN2A mutations (all enrolled in the Phase 2 study). New genetic data (single nucleotide polymorphism microarray data and molecular inversion probe sequencing data) are available for many of the 16p11.2 CNV families enrolled in Phase 1.
Plans are underway to perform whole-genome sequencing of the entire Simons Simplex Collection (SSC). Genomes from 553 families (2,174 genomes) have been sequenced and are available to approved researchers with no publication embargo restrictions. An additional 619 families (2,476 genomes) are currently being sequenced and are expected to be available in the fall of 2016. A four-month publication embargo will apply to that batch of samples. Sequencing of the entire collection is expected to be completed by late 2017.